Package 72603-257-01

{"route": ["ORAL"], "spl_id": "37cc941b-bf1e-1218-4af9-b2e5860871da", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0372603254013"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_set_id": ["5cfca904-b75c-5a39-8cb9-b99bb421bceb"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72603-257-01)", "package_ndc": "72603-257-01", "marketing_start_date": "20241001"}], "brand_name": "EVEROLIMUS", "product_id": "72603-257_37cc941b-bf1e-1218-4af9-b2e5860871da", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "72603-257", "generic_name": "everolimus", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EVEROLIMUS", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "10 mg/1"}], "application_number": "ANDA214182", "marketing_category": "ANDA", "marketing_start_date": "20241001", "listing_expiration_date": "20261231"}